science top stories popular news  

Daily non-political popular news in brief.

Spotlight on liver disease: Improving today's treatments

05-20-2007 · EurekAlert!

Patients with liver disease often suffer from other related illnesses, including type-2 diabetes, obesity and high blood pressure, among others. Research presented today at Digestive Disease Week 2007 explores the many unknowns of liver disease by examining new liver biomarkers, understanding disease complications and assessing novel treatments for their disease-fighting potential. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Read more »

Keywords: spotlight, liver, disease, today, treatments, treatment

« Previous | Next »

Similar news on "Spotlight on liver disease: Improving today's treatments":

  1. Interferon does not slow or stop hepatitis C from worsening, study finds
    11-08-2007 · EurekAlert!
    Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who haven't responded to previous attempts to eradicate the disease, a national study has found. Patients who were treated with interferon did experience a significant decrease in viral levels and liver inflammation, but the trial unequivocally demonstrated that treatment with interferon does not prevent the worsening of liver disease in patients who've failed prior treatments.
    Similar news · Read more »
  2. Novel treatments may help alleviate constipation, IBS in women
    05-21-2007 · EurekAlert!
    Three new therapy options, including two novel medications, showed promise in the treatment of irritable bowel syndrome (IBS), according to research presented today at Digestive Disease Week® 2007 (DDW®).
    Similar news · Read more »
  3. New techniques redefine assessment of liver disease
    05-20-2007 · EurekAlert!
    Research presented today at Digestive Disease Week 2007 introduces unique methods for evaluating patients with non-alcoholic fatty liver disease. NAFLD is the most common liver disease in the world and the development of novel procedures for definitively diagnosing the disease and assessing its prognosis is extremely important for tailoring effective treatments. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
    Similar news · Read more »
  4. New study reveals gender disparity in anti-TNF treatment for rheumatoid arthritis
    06-14-2007 · EurekAlert!
    Findings reported today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, reveal a treatment disparity between female and male patients with rheumatoid arthritis. Data from a study at the Karolinska Institute, Sweden, show that women receive anti-TNFs -- very effective but expensive modern medications against this disease -- at a higher perceived level of disease activity, and when they are reporting more severe pain than their male counterparts.
    Similar news · Read more »
  5. Research shows new therapy is effective for patients with Crohn's disease
    07-18-2007 · EurekAlert!
    Mayo Clinic researchers have found that Certolizumab pegol is an effective treatment for adults with Crohn's disease, according to two new studies. These findings were published in today's issue of the New England Journal of Medicine. Certolizumab pegol blocks tumor necrosis factor, an important cause of inflammation in Crohn's disease
    Similar news · Read more »
  6. Genes linked with lupus are revealed, giving hope for new treatments
    01-20-2008 · EurekAlert!
    Scientists have identified a number of genes involved in lupus, a devastating autoimmune disease, in new research published today in the journal Nature Genetics. In an international genetic study of more than 3,000 women, researchers found evidence of an association between lupus and mutations in several different genes.
    Similar news · Read more »
  7. Scientists develop new treatments for Alzheimer's disease
    10-26-2006 · EurekAlert!
    Scientists at the University of Liverpool have created a new chemical compound that could be developed into a drug treatment for Alzheimer's disease.
    Similar news · Read more »
  8. Alzheimer's disease diagnosed 100 years ago today
    11-03-2006 · EurekAlert!
    One hundred years after the first diagnosis of Alzheimer's disease Nov. 3, 1906, researchers at the Yerkes National Primate Research Center, Emory University, are focusing on neuroscience, immunology and vaccine research to better understand how AD develops and progresses as well as to advance the treatment and prevention of this progressive brain disorder. AD, which currently affects 20 million Americans, gradually destroys memory and the ability to learn, reason, make judgments and communicate.
    Similar news · Read more »
  9. Treatment with Belimumab showed improvement in symptoms in 46 percent of lupus patients at 52 weeks
    06-14-2007 · EurekAlert!
    Treatment with belimumab resulted in a sustained improvement of systemic lupus erythematosus disease activity in 46 percent of patients at week 52, according to a novel combined responder index in results presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
    Similar news · Read more »
  10. Ibuprofen restores learning ability in rats with liver failure
    08-01-2007 · EurekAlert!
    Cognitive impairment is one of the neurological effects in patients with hepatic encephalopathy (abnormal brain function due to severe liver disease). For the first time, a new study showed that treatment with an anti-inflammatory improves cognitive function in rats induced with chronic liver failure.
    Similar news · Read more »